SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-059337
Filing Date
2017-09-28
Accepted
2017-09-28 06:07:02
Documents
5
Period of Report
2017-09-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-22519_18k.htm 8-K 24242
2 EX-99.1 a17-22519_1ex99d1.htm EX-99.1 13225
3 EX-99.2 a17-22519_1ex99d2.htm EX-99.2 8088
4 GRAPHIC g225191mki001.jpg GRAPHIC 4293
5 GRAPHIC g225191mmi001.jpg GRAPHIC 26803
  Complete submission text file 0001104659-17-059337.txt   89760
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36562 | Film No.: 171105493
SIC: 2834 Pharmaceutical Preparations